Russia’s RDIF, Hualan Biological Bacterin Agree to Produce 100Mln Sputnik V Doses in China

Apr 19, 2021 | EARNINGS

MOSCOW (Sputnik) – The Russian Direct Investment Fund (RDIF) announced on Monday that it had reached an agreement with China’s Hualan Biological Bacterin to produce over 100 million doses of Russia’s Sputnik V vaccine against COVID-19 per year in China.

Read More

Pin It on Pinterest